Amarin Corp Plcuk (AMRN) Return on Capital Employed Growth (5y) (2016 - 2026)

Amarin Corp Plcuk (AMRN) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -122.00
Dec 31, 2025 108.00
Sep 30, 2025 -451.00
Jun 30, 2025 -791.00
Mar 31, 2025 -326.00
Dec 31, 2024 -270.00
Sep 30, 2024 1,719.00
Jun 30, 2024 4,285.00
Mar 31, 2024 4,857.00
Dec 31, 2023 7,457.00
Sep 30, 2023 13,805.00
Jun 30, 2023 8,706.00
Mar 31, 2023 5,535.00
Dec 31, 2022 6,537.00
Sep 30, 2022 -747.00
Jun 30, 2022 -234.00
Mar 31, 2022 1,220.00
Dec 31, 2021 1,869.00
Sep 30, 2021 7,486.00
Jun 30, 2021 11,447.00